We successfully developed a microneedle patch system integrated with H ₂ O ₂ -responsive mesoporous silica nanoparticles for the glucose-monitored transdermal delivery of insulin.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: